How We Can Support the Drug Development Pipeline

Molecular testing and Companion Diagnostics

Source BioScience supports Pharma Biotech clients in the market place by providing services for the development and validation of companion diagnostics for new drug launch. Our personalised medicine diagnostic services also give support to physicians, enabling them to provide the best drug choice for their patients, and providing the patients with the best possible treatment.
Using our fully accredited facilities, our team of pathologists, physicians, molecular biologists and scientists are there to help you meet your drug launch goals and facilitate introduction of new drugs into the market place.

Source BioScience can help to develop and validate molecular tests for mutation analysis. We offer a suite of tests to support patient stratification for research and clinical trial studies, including rtPCR, capillary sequencing, pyrosequencing and next generation sequencing analysis. We also specialise in cell signalling pathway analysis, able to offer reflex testing for EGFR, detecting multiple mutations along the EGFR signalling pathway. This is supported by a comprehensive bioinformatics portfolio. To discuss your project requirements please contact us at pharma.